World

Top 413 largest Companies in the Drug Manufacturers—Specialty & Generic industry in the World by Market Cap

This is the list of the largest public listed companies in the Drug Manufacturers—Specialty & Generic industry in the world by market capitalization with links to their reference stock.

World Drug Manufacturers—Specialty & Generic Industry Analysis
World Top Companies World Companies Analysis

Top Drug Manufacturers—Specialty & Generic Companies in the World as of Jul. 01, 2025

Rank Company Market Cap (USD) Country Sector Industry
241 Hana Pharm Co. Ltd $156.6 M South Korea South Korean Healthcare South Korean Drug Manufacturers—Specialty & Generic
242 Jilin Province Huinan Changlong Bio-pharmacy Company Ltd $154.9 M China Chinese Healthcare Chinese Drug Manufacturers—Specialty & Generic
243 Jeil Pharmaceutical Co.,Ltd $153.6 M South Korea South Korean Healthcare South Korean Drug Manufacturers—Specialty & Generic
244 PhotoCure ASA $148.3 M

(July 1, 2024)

 Norway Norway Healthcare Norway Drug Manufacturers—Specialty & Generic
245 HAEMATO AG $144.4 M

(Jan. 1, 2024)

 Germany German Healthcare German Drug Manufacturers—Specialty & Generic
246 JW Lifescience Corp $141.5 M South Korea South Korean Healthcare South Korean Drug Manufacturers—Specialty & Generic
247 Theratechnologies Inc. $140.9 M Canada Canadian Healthcare Canadian Drug Manufacturers—Specialty & Generic
248 Olainfarm AS $138.5 M

(Dec. 1, 2021)

 Latvia Latvia Healthcare Latvia Drug Manufacturers—Specialty & Generic
249 Planet 13 Holdings, Inc. $133.9 M

(July 1, 2023)

 United States US Healthcare US Drug Manufacturers—Specialty & Generic
250 Ignite International Brands Ltd $132.2 M

(Aug. 1, 2022)

 Canada Canadian Healthcare Canadian Drug Manufacturers—Specialty & Generic
251 Lincoln Pharmaceuticals Ltd $131.5 M India Indian Healthcare Indian Drug Manufacturers—Specialty & Generic
252 Fuso Pharmaceutical Industries,Ltd. $124.8 M Japan Japanese Healthcare Japanese Drug Manufacturers—Specialty & Generic
253 Cardiol Therapeutics Inc. $124.8 M Canada Canadian Healthcare Canadian Drug Manufacturers—Specialty & Generic
254 DV Biomed Co. Ltd $124.4 M

(Nov. 1, 2021)

 Taiwan Taiwanese Healthcare Taiwanese Drug Manufacturers—Specialty & Generic
255 Ironwood Pharmaceuticals, Inc. $124.0 M United States US Healthcare US Drug Manufacturers—Specialty & Generic
256 Incannex Healthcare Limited $116.3 M

(July 1, 2023)

 Australia Australian Healthcare Australian Drug Manufacturers—Specialty & Generic
257 AB Science SA $114.8 M France French Healthcare French Drug Manufacturers—Specialty & Generic
258 HLS Therapeutics Inc. $114.5 M Canada Canadian Healthcare Canadian Drug Manufacturers—Specialty & Generic
259 PT Darya-Varia Laboratoria Tbk $110.1 M Indonesia Indonesian Healthcare Indonesian Drug Manufacturers—Specialty & Generic
260 BioHarvest Sciences, Inc. $109.9 M Canada Canadian Healthcare Canadian Drug Manufacturers—Specialty & Generic
261 Venture Life Group plc $106.5 M United Kingdom UK Healthcare UK Drug Manufacturers—Specialty & Generic
262 Cannara Biotech, Inc. $103.9 M Canada Canadian Healthcare Canadian Drug Manufacturers—Specialty & Generic
263 Nutritional High International, Inc. $102.2 M

(Nov. 1, 2021)

 Canada Canadian Healthcare Canadian Drug Manufacturers—Specialty & Generic
264 Johnson Chemical Pharmaceutical Works Co. Ltd $99.6 M Taiwan Taiwanese Healthcare Taiwanese Drug Manufacturers—Specialty & Generic
265 Taiko Pharmaceutical Co.,Ltd. $99.4 M Japan Japanese Healthcare Japanese Drug Manufacturers—Specialty & Generic
266 Maywufa Company Ltd $99.4 M Taiwan Taiwanese Healthcare Taiwanese Drug Manufacturers—Specialty & Generic
267 Biosyent, Inc. $98.8 M Canada Canadian Healthcare Canadian Drug Manufacturers—Specialty & Generic
268 Recro Pharma, Inc. $97.4 M

(June 1, 2022)

 United States US Healthcare US Drug Manufacturers—Specialty & Generic
269 Shineco, Inc. $97.2 M

(June 1, 2022)

 China Chinese Healthcare Chinese Drug Manufacturers—Specialty & Generic
270 Dali Pharmaceutical Co. Ltd $96.9 M

(Jan. 1, 2025)

 China Chinese Healthcare Chinese Drug Manufacturers—Specialty & Generic

Top Drug Manufacturers—Specialty & Generic Companies in the World as of Jul. 01, 2025

241. Hana Pharm Co. Ltd

Company Profile: Hana Pharm Co. Ltd
Market Cap (USD): $156.6 M
Country: South Korea
Sector: South Korean Healthcare
Industry: South Korean Drug Manufacturers—Specialty & Generic

242. Jilin Province Huinan Changlong Bio-pharmacy Company Ltd

Company Profile: Jilin Province Huinan Changlong Bio-pharmacy Company Ltd
Market Cap (USD): $154.9 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Drug Manufacturers—Specialty & Generic

243. Jeil Pharmaceutical Co.,Ltd

Company Profile: Jeil Pharmaceutical Co.,Ltd
Market Cap (USD): $153.6 M
Country: South Korea
Sector: South Korean Healthcare
Industry: South Korean Drug Manufacturers—Specialty & Generic

244. PhotoCure ASA

Company Profile: PhotoCure ASA
Market Cap (USD): $148.3 M (July 1, 2024)
Country: Norway
Sector: Norway Healthcare
Industry: Norway Drug Manufacturers—Specialty & Generic

245. HAEMATO AG

Company Profile: HAEMATO AG
Market Cap (USD): $144.4 M (Jan. 1, 2024)
Country: Germany
Sector: German Healthcare
Industry: German Drug Manufacturers—Specialty & Generic

246. JW Lifescience Corp

Company Profile: JW Lifescience Corp
Market Cap (USD): $141.5 M
Country: South Korea
Sector: South Korean Healthcare
Industry: South Korean Drug Manufacturers—Specialty & Generic

247. Theratechnologies Inc.

Company Profile: Theratechnologies Inc.
Market Cap (USD): $140.9 M
Country: Canada
Sector: Canadian Healthcare
Industry: Canadian Drug Manufacturers—Specialty & Generic

248. Olainfarm AS

Company Profile: Olainfarm AS
Market Cap (USD): $138.5 M (Dec. 1, 2021)
Country: Latvia
Sector: Latvia Healthcare
Industry: Latvia Drug Manufacturers—Specialty & Generic

249. Planet 13 Holdings, Inc.

Company Profile: Planet 13 Holdings, Inc.
Market Cap (USD): $133.9 M (July 1, 2023)
Country: United States
Sector: US Healthcare
Industry: US Drug Manufacturers—Specialty & Generic

250. Ignite International Brands Ltd

Company Profile: Ignite International Brands Ltd
Market Cap (USD): $132.2 M (Aug. 1, 2022)
Country: Canada
Sector: Canadian Healthcare
Industry: Canadian Drug Manufacturers—Specialty & Generic

251. Lincoln Pharmaceuticals Ltd

Company Profile: Lincoln Pharmaceuticals Ltd
Market Cap (USD): $131.5 M
Country: India
Sector: Indian Healthcare
Industry: Indian Drug Manufacturers—Specialty & Generic

252. Fuso Pharmaceutical Industries,Ltd.

Company Profile: Fuso Pharmaceutical Industries,Ltd.
Market Cap (USD): $124.8 M
Country: Japan
Sector: Japanese Healthcare
Industry: Japanese Drug Manufacturers—Specialty & Generic

253. Cardiol Therapeutics Inc.

Company Profile: Cardiol Therapeutics Inc.
Market Cap (USD): $124.8 M
Country: Canada
Sector: Canadian Healthcare
Industry: Canadian Drug Manufacturers—Specialty & Generic

254. DV Biomed Co. Ltd

Company Profile: DV Biomed Co. Ltd
Market Cap (USD): $124.4 M (Nov. 1, 2021)
Country: Taiwan
Sector: Taiwanese Healthcare
Industry: Taiwanese Drug Manufacturers—Specialty & Generic

255. Ironwood Pharmaceuticals, Inc.

Company Profile: Ironwood Pharmaceuticals, Inc.
Market Cap (USD): $124.0 M
Country: United States
Sector: US Healthcare
Industry: US Drug Manufacturers—Specialty & Generic

256. Incannex Healthcare Limited

Company Profile: Incannex Healthcare Limited
Market Cap (USD): $116.3 M (July 1, 2023)
Country: Australia
Sector: Australian Healthcare
Industry: Australian Drug Manufacturers—Specialty & Generic

257. AB Science SA

Company Profile: AB Science SA
Market Cap (USD): $114.8 M
Country: France
Sector: French Healthcare
Industry: French Drug Manufacturers—Specialty & Generic

258. HLS Therapeutics Inc.

Company Profile: HLS Therapeutics Inc.
Market Cap (USD): $114.5 M
Country: Canada
Sector: Canadian Healthcare
Industry: Canadian Drug Manufacturers—Specialty & Generic

259. PT Darya-Varia Laboratoria Tbk

Company Profile: PT Darya-Varia Laboratoria Tbk
Market Cap (USD): $110.1 M
Country: Indonesia
Sector: Indonesian Healthcare
Industry: Indonesian Drug Manufacturers—Specialty & Generic

260. BioHarvest Sciences, Inc.

Company Profile: BioHarvest Sciences, Inc.
Market Cap (USD): $109.9 M
Country: Canada
Sector: Canadian Healthcare
Industry: Canadian Drug Manufacturers—Specialty & Generic

261. Venture Life Group plc

Company Profile: Venture Life Group plc
Market Cap (USD): $106.5 M
Country: United Kingdom
Sector: UK Healthcare
Industry: UK Drug Manufacturers—Specialty & Generic

262. Cannara Biotech, Inc.

Company Profile: Cannara Biotech, Inc.
Market Cap (USD): $103.9 M
Country: Canada
Sector: Canadian Healthcare
Industry: Canadian Drug Manufacturers—Specialty & Generic

263. Nutritional High International, Inc.

Company Profile: Nutritional High International, Inc.
Market Cap (USD): $102.2 M (Nov. 1, 2021)
Country: Canada
Sector: Canadian Healthcare
Industry: Canadian Drug Manufacturers—Specialty & Generic

264. Johnson Chemical Pharmaceutical Works Co. Ltd

Company Profile: Johnson Chemical Pharmaceutical Works Co. Ltd
Market Cap (USD): $99.6 M
Country: Taiwan
Sector: Taiwanese Healthcare
Industry: Taiwanese Drug Manufacturers—Specialty & Generic

265. Taiko Pharmaceutical Co.,Ltd.

Company Profile: Taiko Pharmaceutical Co.,Ltd.
Market Cap (USD): $99.4 M
Country: Japan
Sector: Japanese Healthcare
Industry: Japanese Drug Manufacturers—Specialty & Generic

266. Maywufa Company Ltd

Company Profile: Maywufa Company Ltd
Market Cap (USD): $99.4 M
Country: Taiwan
Sector: Taiwanese Healthcare
Industry: Taiwanese Drug Manufacturers—Specialty & Generic

267. Biosyent, Inc.

Company Profile: Biosyent, Inc.
Market Cap (USD): $98.8 M
Country: Canada
Sector: Canadian Healthcare
Industry: Canadian Drug Manufacturers—Specialty & Generic

268. Recro Pharma, Inc.

Company Profile: Recro Pharma, Inc.
Market Cap (USD): $97.4 M (June 1, 2022)
Country: United States
Sector: US Healthcare
Industry: US Drug Manufacturers—Specialty & Generic

269. Shineco, Inc.

Company Profile: Shineco, Inc.
Market Cap (USD): $97.2 M (June 1, 2022)
Country: China
Sector: Chinese Healthcare
Industry: Chinese Drug Manufacturers—Specialty & Generic

270. Dali Pharmaceutical Co. Ltd

Company Profile: Dali Pharmaceutical Co. Ltd
Market Cap (USD): $96.9 M (Jan. 1, 2025)
Country: China
Sector: Chinese Healthcare
Industry: Chinese Drug Manufacturers—Specialty & Generic

Stay in touch